Lupin (LUPIN) — Announcement

Lupin announced the completion of its cash acquisition of 100% of Renascience Pharma Limited, a UK specialty pharma with GBP 3.51 million turnover, for GBP 12.3 million, immediately closing the deal on April 2, 2025, to expand its UK specialty portfolio with four niche products including XAQUA and OTIGO that serve unmet NHS needs.

📄 View Original Announcement (PDF)

📊 Stock Analysis — LUPIN ✨ Ask AI About This

About Lupin Limited (LUPIN)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,04,071.47 Cr P/E: 36.2

View full LUPIN stock details →

📡 Get AI alerts when LUPIN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LUPIN — Free

💡 Ask AI about this filing

"How does this announcement affect Lupin Limited's outlook?" "What did Lupin Limited announce on 2 April 2025?" "Is this positive or negative for LUPIN?"

Ask AI Free →

📊 More LUPIN filings

See all LUPIN filings →

🔥 Also filed on 2 April 2025

SRF SRF Limited Announcement BANKBARODA Bank of Baroda Insider Trading INDHOTEL The Indian Hotels Company Limited Announcement WIPRO Wipro Limited Financial Results PNB Punjab National Bank Insider Trading ONGC Oil & Natural Gas Corporation Limited Board Meeting

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LUPIN files new disclosures

Track LUPIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.